Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Liu JY et al
Follow your trial team's guidance on glucose monitoring and dose adjustment
Two participants who received apitegromab discontinued treatment
They were developed to mimic glucagon-like peptide-1, a hormone that regulates insulin secretion and appetite
Contraindications include personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, or severe kidney disease
Side effects of stimulants can include insomnia, high blood pressure, fast heart rate, headache, and loss of appetite
US$ 21.68
US$ 20.95
US$ 23.98
US$ 28.75
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 20.43
US$ 20.16
